TABLE 2.
Univariate and multivariate analysis on the correlation between clinicopathological variables and relapse free survival (RFS) of the patients who underwent curative surgery for gastric cancer with macroscopic serosal exposure (T4)
| Variables | Univariate analysis | Multivariate analysis | |||||
|---|---|---|---|---|---|---|---|
| HR | 95% CI | p value | HR | 95% CI | p value | ||
| Age | (71≤/<70) | 2.65 | 0.792–8.867 | .114 | 1.094 | 0.261–4.579 | .901 |
| Gender | (F/M) | 0.866 | 0.273–2.750 | .807 | |||
| Macroscopic type | (type IV/nontype IV) | 3.393 | 1.316–14.660 | .016 | 5.447 | 1.478–20.080 | .011 |
| Operation | (Total gastrectomy/distal gastrectomy) | 0.783 | 0.252–2.429 | .672 | |||
| Pathological type | (undifferentiated/differentiated) | 1.352 | 0.358–5.109 | .657 | |||
| Pathological T | (t4/t3) | 1.209 | 0.262–5.586 | .808 | |||
| Pathological N | (n2–3/n0–1) | 3.278 | 0.423–25.420 | .256 | |||
| TLR | (0.0559%>/<0.0559%) | 17.31 | 3.538–77.200 | .0004 | 19.87 | 3.073–128.500 | .002 |
Abbreviations: CI, confidence interval; HR, hazard ratio; RFS, relapse free survival; TLR, tumor‐leukocyte ratio.